Wire · operational-macro
As clinical trials surge into Australia, HHS targets US bottlenecks
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 29 August 2026 · Fusion42 review
The US Department of Health and Human Services launched Operation TrialBlazer to accelerate domestic Phase 1 clinical trials, aiming to counter the growth of US-sponsored trials taking place in Australia, which offers faster trial start-up times. The US sees this as a national security and biopharma innovation priority amid competition with China.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You must rethink US trial strategy as Australia’s speed advantage drives sponsors offshore. The TrialBlazer reforms create a narrow window to speed domestic launches before the US loses more early-stage trials.
◆ Coverage
1 source · 28 Aug 2026
◆ Related on Wire
◆ Topics